NTC ACQUIRES FROM NMTECH UK TiAb AND SIAB BASED TECHNOLOGY

NTC ACQUIRES FROM NMTECH UK TiAb AND SIAB BASED TECHNOLOGY

  • June 12, 2019

Milan, Italy, June 12, 2019 – NTC announces the acquisition of the license and the know-how to produce and sell TiAb and SIAB based products from NMTech UK, R&D company focused on development of medical devices with properties to treat skin and mucosal lesions.

 

  Read more

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE